# United Therapeutics (UTHR): value investors who own it

0 value investors held United Therapeutics in their Q3 2026 13F. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Mairs & Power | 0.0% | $0k | Sold out | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 1800 | $973k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 1240 | $674k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 1065 | $581k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 1040 | $567k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 880 | $475k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 559 | $306k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 520 | $282k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 416 | $228k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 360 | $198k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 360 | $193k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 260 | $141k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 240 | $129k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 160 | $86k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 160 | $86k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 120 | $66k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 120 | $66k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 80 | $45k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 80 | $44k |
| 2026-10-19 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 40 | $22k |
| 2026-10-16 | ROTHBLATT MARTINE A | Chairperson & CEO | Sold | 2378 | $1.3m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/uthr). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.